Chronic Functional Constipation. Constipation, Functional intestinal disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Married women aged 20–50 years Diagnosis of Chronic functional constipation (CFC) confirmed by a colorectal specialist or gastroenterologist History of constipation symptoms for at least six months Presence of at least two myofascial trigger points in the abdominal and pelvic muscle groups , with at least one trigger point located in the pelvic floor muscles.
Exclusion criteria
Exclusion criteria: Pregnancy Presence of anal fissure History of anorectal surgery Constipation associated with alternating diarrhea Needle phobia (belonephobia) Diagnosed depression and/ or anxiety requiring pharmacological treatment Current use of oral or injectable anticoagulant or antiplatelet medications Presence of structural anorectal disorders requiring surgical intervention Diagnosed neurological disorders affecting bowel or pelvic floor function (e.g., multiple sclerosis, stroke, Parkinson’s disease, spinal cord injury) Change in constipation medication dosage within one month prior to enrollment Use of constipation-inducing medications (e.g., opioids) not discontinued at least two weeks before study enrollment Unwillingness or inability to provide informed consent Inability to comply with study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Chronic Functional Constipation. Timepoint: It is checked at the baseline (before the intervention) and immediately after the final treatment session. Method of measurement: Persian version of Wexner Constipation Scoring System. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic floor muscle function (activity and strength). Timepoint: It is checked at the baseline (before the intervention) and immediately after the final treatment session. Method of measurement: Pelvic floor muscle function, encompassing both activity and strength, will be assessed. Muscle activity will be measured using electromyographic biofeedback, while muscle strength will be evaluated using the Modified Oxford Scale.;Quality of Life. Timepoint: It is checked at the baseline (before the intervention) and immediately after the final treatment session. Method of measurement: Persian version of Patient Assessment of Constipation Quality of Life (PAC QOL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences